Rubius Therapeutics Price History

RUBYDelisted Stock  USD 0.08  0.02  17.00%   
If you're considering investing in Rubius Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Rubius Therapeutics stands at 0.08, as last reported on the 27th of November, with the highest price reaching 0.10 and the lowest price hitting 0.08 during the day. We have found twenty-four technical indicators for Rubius Therapeutics, which you can use to evaluate the volatility of the company. Please check Rubius Therapeutics' Risk Adjusted Performance of (0.02), variance of 177.53, and Coefficient Of Variation of (2,402) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Rubius Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
RUBY
Based on monthly moving average Rubius Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rubius Therapeutics by adding Rubius Therapeutics to a well-diversified portfolio.

Rubius Therapeutics Pink Sheet Price History Chart

There are several ways to analyze Rubius Stock price data. The simplest method is using a basic Rubius candlestick price chart, which shows Rubius Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Rubius Pink Sheet Price History Data

The price series of Rubius Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.26 with a coefficient of variation of 26.81. The price distribution for the period has arithmetic mean of 0.2. The median price for the last 90 days is 0.18.
OpenHighLowCloseVolume
11/27/2024
 0.10  0.10  0.08  0.08 
03/06/2023 0.10  0.10  0.08  0.08  17,939,553 
03/03/2023 0.15  0.15  0.12  0.13  22,216,800 
03/02/2023 0.12  0.13  0.1  0.11  11,970,948 
03/01/2023 0.14  0.14  0.11  0.12  6,643,301 
02/28/2023 0.13  0.15  0.12  0.15  15,112,255 
02/27/2023 0.13  0.19  0.12  0.13  33,741,025 
02/24/2023 0.14  0.14  0.11  0.12  5,474,200 
02/23/2023 0.14  0.16  0.13  0.14  2,717,500 
02/22/2023 0.16  0.17  0.14  0.15  4,247,300 
02/21/2023 0.17  0.17  0.16  0.17  1,325,936 
02/17/2023 0.18  0.18  0.17  0.17  1,534,000 
02/16/2023 0.17  0.18  0.17  0.18  2,074,300 
02/15/2023 0.17  0.18  0.16  0.17  3,942,086 
02/14/2023 0.25  0.34  0.17  0.18  46,031,895 
02/13/2023 0.21  0.21  0.17  0.19  705,600 
02/10/2023 0.19  0.20  0.19  0.19  664,935 
02/09/2023 0.23  0.23  0.18  0.19  1,356,309 
02/08/2023 0.25  0.25  0.21  0.23  1,122,048 
02/07/2023 0.28  0.28  0.24  0.26  2,330,966 
02/06/2023 0.28  0.34  0.27  0.34  1,693,698 
02/03/2023 0.29  0.31  0.28  0.28  563,751 
02/02/2023 0.27  0.32  0.27  0.29  1,518,291 
02/01/2023 0.25  0.27  0.25  0.27  367,674 
01/31/2023 0.24  0.27  0.24  0.26  201,403 
01/30/2023 0.26  0.28  0.25  0.25  337,771 
01/27/2023 0.28  0.28  0.27  0.28  508,381 
01/26/2023 0.27  0.28  0.25  0.28  350,496 
01/25/2023 0.25  0.27  0.23  0.27  723,302 
01/24/2023 0.25  0.27  0.24  0.26  1,111,566 
01/23/2023 0.23  0.25  0.22  0.25  578,042 
01/20/2023 0.23  0.24  0.21  0.23  975,014 
01/19/2023 0.24  0.25  0.22  0.23  665,406 
01/18/2023 0.25  0.27  0.24  0.24  811,870 
01/17/2023 0.29  0.29  0.24  0.25  1,704,037 
01/13/2023 0.28  0.31  0.27  0.29  2,358,958 
01/12/2023 0.22  0.29  0.22  0.28  3,917,119 
01/11/2023 0.23  0.24  0.22  0.23  911,718 
01/10/2023 0.18  0.27  0.18  0.24  7,252,994 
01/09/2023 0.19  0.20  0.17  0.18  772,330 
01/06/2023 0.21  0.21  0.15  0.18  1,924,192 
01/05/2023 0.16  0.22  0.16  0.21  2,422,126 
01/04/2023 0.17  0.17  0.15  0.16  1,308,994 
01/03/2023 0.18  0.19  0.16  0.16  1,660,154 
12/30/2022 0.18  0.20  0.16  0.18  2,048,043 
12/29/2022 0.22  0.23  0.18  0.19  3,689,682 
12/28/2022 0.14  0.42  0.14  0.24  18,668,390 
12/27/2022 0.15  0.18  0.15  0.16  1,155,409 
12/23/2022 0.16  0.16  0.14  0.15  349,200 
12/22/2022 0.15  0.16  0.14  0.15  289,200 
12/21/2022 0.16  0.16  0.14  0.15  393,700 
12/20/2022 0.15  0.15  0.14  0.14  615,800 
12/19/2022 0.16  0.16  0.14  0.15  720,789 
12/16/2022 0.17  0.18  0.16  0.16  780,071 
12/15/2022 0.18  0.19  0.17  0.18  467,953 
12/14/2022 0.19  0.19  0.16  0.17  445,830 
12/13/2022 0.17  0.18  0.16  0.18  686,889 
12/12/2022 0.18  0.18  0.16  0.16  467,786 
12/09/2022 0.18  0.20  0.16  0.17  730,612 
12/08/2022 0.17  0.19  0.17  0.17  646,015 
12/07/2022 0.17  0.19  0.16  0.17  410,785 

About Rubius Therapeutics Pink Sheet history

Rubius Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rubius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rubius Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rubius Therapeutics stock prices may prove useful in developing a viable investing in Rubius Therapeutics
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of patients with severe diseases. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Rubius Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 213 people.

Rubius Therapeutics Pink Sheet Technical Analysis

Rubius Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Rubius Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rubius Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Rubius Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Rubius Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Rubius Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rubius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Rubius Pink Sheet

If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device